Pfizer's incoming commercial chief inherits a patent-cliff calendar, not a pipeline

NEW YORK — The job is to sell what still has exclusivity and to stop pretending the next decade looks like the last one.

The incoming officer has been asked for a brand-by-brand defense plan through 2029, according to two people who have seen the mandate — less moonshot, more math.